Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.04M
-
Shares change
-
-33.1K
-
Total reported value, excl. options
-
$2.61M
-
Value change
-
-$42.9K
-
Put/Call ratio
-
0
-
Number of buys
-
7
-
Number of sells
-
-6
-
Price
-
$1.28
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2024
26 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2024.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04M shares
of 15M outstanding shares and own 13.66% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (528K shares), VANGUARD GROUP INC (374K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (287K shares), DIMENSIONAL FUND ADVISORS LP (284K shares), ACADIAN ASSET MANAGEMENT LLC (188K shares), BlackRock, Inc. (110K shares), Bank of New York Mellon Corp (75.3K shares), GEODE CAPITAL MANAGEMENT, LLC (74.3K shares), STATE STREET CORP (33.7K shares), and Cresset Asset Management, LLC (21.3K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.